Close Menu
January 26, 2021
Sponsored by
LGC, Biosearch Technologies

Panel Discussion: Genotyping by Sequencing for Novel SNP Discovery with Less Common Genomes

GenomeWebinar

Director of Aquaculture Innovation,
Atlantic Aqua Farms

Lead Scientist, Variety Development and Bioinformatics,
Hopsteiner

Genomics Coordinator, The Center for Aquaculture Technologies (CAT)

Global Strategic Marketing Manager,
LGC, Biosearch Technologies

Reduced representation next-generation sequencing (NGS) methods are driving understanding of both physical and structural variation in all species. But these services are not created equal. The diversity of species means that not all breeding programs can rely on well-defined reference genomes. For many species, customized enzymes and expertise help uncover more variations and make more informative decisions on breeding selections.

For example, genotyping by sequencing (GBS) is a useful approach for species where there is little or no previous genetic information available. The approach provides a means for SNP discovery for lesser interrogated species and unique populations where whole-genome sequencing would not be financially feasible due to complexities and larger genome sizes.

In this panel discussion, three experts will talk through applications of targeted genotyping by sequencing, specifically focusing on how customized enzymes coupled with expertise from LGC, Biosearch Technologies, improved their breeding programs.

Sponsored by

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
12
Sponsored by
Combinati

This webinar will discuss a recent study that characterized the relationships between SARS-CoV-2 RNAemia and disease severity, clinical deterioration, and extrapulmonary complications (EPCs).

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.  

Jun
18
Sponsored by
Canexia Health

Last year, by Precision Oncology News' count, the FDA approved 27 precision oncology drugs, a 35 percent increase in the number of approvals from 2019.